Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Jefferam1on Mar 20, 2018 12:25pm

176 Views

Post# 27747071

RE:RE:Hows Everyones Day

I agree, my day is fantastic.
I was trying to set myself up for worst case so I'd be prepared with loosing all that money. Glad that didn't play out.
Now that I had lived that fear, I did take small profits selling about 15% of my shares.
If I would of sold 20% I'd be sitting in the clear. If we get back up to 0.75 today I might sell another 5%, but that's it.
Now we wait.

Today is a great day.
I expect to see Zacks with a new report soon.
David has already tweeted about results, it's obviously on his radar. Will be interesting to see what happens.
https://twitter.com/DavidBautz/status/976096923714236416

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading